Medical Oncology · Acibadem Maslak Hospital, İstanbul Prof. Özlem Er, MD
✓ Medically verified profileProf. Özlem Er, MD
Prof. Özlem Er, MD is a medical oncologist in the Medical Oncology Department at Acibadem Maslak Hospital in İstanbul. She treats solid tumors, including head and neck cancers, oral and tongue cancers, brain tumors, kidney and adrenal gland cancers, lung and other thoracic cancers, anal cancer, malignant melanoma, and other skin tumors. She consults in Turkish and English.
Accepting international patientsAbout Prof. Özlem Er, MD
Prof. Özlem Er, MD is a medical oncologist in the Medical Oncology Department at Acibadem Maslak Hospital in İstanbul. She cares for adults with a range of solid tumors, including head and neck cancers, lung and other thoracic cancers, kidney and adrenal gland cancers, brain tumors, anal cancer, and melanoma and other skin tumors. She has more than 32 years of experience in medicine and joined Acıbadem Healthcare Services in 2018.
Dr. Er graduated from Hacettepe University Faculty of Medicine in 1994. She completed her specialization in Internal Medicine at Ankara Numune Training and Research Hospital between 1994 and 1999, followed by specialization in Medical Oncology at Erciyes University Faculty of Medicine, completed in 2002. She was appointed Associate Professor in 2003 and became a Professor at Acıbadem University Faculty of Medicine in 2010. From 2002 to 2009 she was a faculty member in the Division of Medical Oncology at Erciyes University, where she also chaired the Department of Medical Oncology from 2005 to 2007. Her international experience includes a period as a clinical observer in breast cancer clinical research at MD Anderson Cancer Center (2003–2004) and as a research fellow in breast cancer research at Thomas Jefferson University (2006–2008). She is a member of ASCO, ESMO, the Turkish Oncology Group, the Medical Oncology Association, and the Turkish Cancer Research and Control Institution Association. Her published work covers topics such as chemotherapy in metastatic gastric cancer, low-molecular-weight heparin in small cell lung cancer, the management of cancer-associated venous thrombosis, and the clinical course of breast cancer patients with metastases limited to the liver.
Clinical focus
Dr. Er’s clinical work centers on the medical oncology management of solid tumors. Within head and neck cancers, her areas of expertise include oral cancer, tongue and base-of-tongue cancer, and intranasal tumors. She also sees patients with brain tumors and with lung and other thoracic cancers.
Her expertise further extends to kidney cancer, adrenal gland cancer, and anal cancer, as well as malignant melanoma and other skin tumors. As a medical oncologist, she assesses systemic treatment options as part of a patient’s overall care. Whether and how a given treatment is appropriate depends on the individual diagnosis, stage, and general health, and is decided after a review of each patient’s records and findings.
How Dr. Er works with international patients
Dr. Er consults in Turkish and English. The international patient team coordinates the transfer of medical reports, pathology results, and imaging ahead of a visit and arranges appointments. A first consultation typically covers a review of the medical history and existing test results, a discussion of the diagnosis, and an outline of the treatment options that may be considered; further tests may be requested where needed. Video consultation is available for international patients who wish to discuss their case before traveling or as part of follow-up.
What Dr. Er treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Conditions treated
- Oral cancer
- Head and neck cancers
- Brain tumors
- Kidney cancer
- Adrenal gland cancer
- Lung and other thoracic cancers
- Tongue and base-of-tongue cancer
- Anal cancer
Procedures performed
Education, career and memberships
Education & training
Education
- 2010Acıbadem University Faculty of Medicine / Professor
- 2003Erciyes University Faculty of Medicine / Associate Professor
- 2002Erciyes University Faculty of Medicine Medical Oncology
- 1999Ankara Numune Training and Research Hospital Internal Medicine
- 1994Hacettepe University Faculty of Medicine
Career
Professional Experience
- 2018Acıbadem Healthcare Services
- 2006–2008Thomas Jefferson University Breast Cancer Research (Research Fellow)
- 2005–2007Erciyes University Faculty of Medicine Department of Medical Oncology Chair
- 2003–2004MD Anderson Cancer Center Breast Cancer Clinical Research (Clinical Observer)
- 2002–2009Erciyes University Faculty of Medicine Department of Internal Medicine Division of Medical Oncology, Faculty Member
- 1999–2002Erciyes University Faculty of Medicine Medical Oncology Specialization
- 1994–1999Ankara Numune Training and Research Hospital Internal Medicine Specialization
Memberships
Professional Memberships
- ASCO (American Society Of Clinical Oncology)
- ESMO (European Society or Medical Oncology)
- Turkish Oncology Group
- Medical Oncology Association
- Turkish Cancer Research and Control Institution Association
Selected publications
Selected Publications
- Cyclooxygenase-2 expression in gastrointestinal stromal tumors. Asian Pac J Cancer Prev. 2010;11(4):849-53 Sevinc A, Camci C, Sari I, Kalender ME, Er O, Soyuer I, Dikilitas M, Yilmaz U, Sagol O, Alacacioglu A.
- Intramuscular metastases detected by PET/CT in a patient with renal cell tumor. V Beylergil, O. Er, Z. Calıkuşu, E. Vardareli. Acibadem University Journal of Health Sciences 2010: 1: 49-50
- Capecitabine:Use except in breast and colorectal cancers. Remission Journal of Current Oncology 2010: 10 (1): 27-39 Ozlem Er, Halit Karaca.
- ERCC1 is not expressed in hepatocellular cancer: A Turkish Oncology Group. Journal of BUON 2010;15:794-796 N. Serdar Turhal, E. Bas, O. Er, M. Aliustaoglu, S. Seber, F. Dane, T. Korkmaz, I. Soyuer, S. Ozkara, C. Celikel.
- Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer. Asian Pac J Cancer Prev. 2010;11(1):181-5 Ozkan M, Akbudak IH, Deniz K, Dikilitas M, Dogu GG, Berk V, Karaca H, Er O, Altinbas M.
- Clinical Course Of Breast Cancer Patients With Metastases Limited To The Liver Treated With Chemotherapy. Er O, Frye Dk, Kau Sw, Broglio K, Valero V, Hortobagyi Gn, Arun B.Cancer J. 2008
- Protective Effects Of Carvedilol Against Anthracycline-Induced Cardiomyopathy. Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A, Inanc T, Oguzhan A, Eryol Nk, Topsakal R, Ergin A. J Am Coll Cardiol. 2006
- Management of Cancer-Associated Venous Thrombosis. Er O, Zacharski L. Vasc Health Risk Manag. 2006
- Irinotecan Plus Cisplatin Combination Against Metastatic Gastric Cancer: Phase Ii Study. Altinbas M, Er O, Ozkan M, Solak Y, Coskun Hs, Kucuk C, Gursoy S. Med Oncol. 2005
- A Randomized Clinical Trial Of Combination Chemotherapy With And Without Low-Molecular-Weight Heparin In Small Cell Lung Cancer. Altinbas M, Coskun Hs, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S. J Thromb Haemost. 2004
